A randomised phase III study of 72 hour infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3)

J. Shamash (Lead / Corresponding author), S. J. Sarker, R. Huddart, S. Harland, J. K. Joffe, D. Mazhar, A. Birtle, J. White, K. Chowdhury, P. Wilson, M. R. Marshall, S. Vinnicombe

    Research output: Contribution to journalArticlepeer-review

    8 Citations (Scopus)
    187 Downloads (Pure)

    Fingerprint Dive into the research topics of 'A randomised phase III study of 72 hour infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3)'. Together they form a unique fingerprint.

    Medicine & Life Sciences